Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.06 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | reachable by antibody | 0.45 |
| trials ClinicalTrials.gov | 27 Parkinson's trials, 2 stopped | 0.94 |
| literature PubMed | 154 Parkinson's papers of 40,060 | 0.34 |
| pathways Reactome | 7 pathways; mostly other | 0.30 |
No case: the score is under the bar. Receipt 4526
Sealed predictions
- FAS in dopamine neurons, braak+0.37 (p 0.323) → -0.26 (p 0.493)receipt 4534
Swarm cases
receipt 4534: FAS in dopamine neurons, braak
- power
- full sample +0.15 (p 0.555, n 18), 95% CI -0.34 to +0.58. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.16 (p 0.521, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.23 (p 0.360, n 18). could be the mix.
- skeptic
- leave-one-out range +0.03 to +0.24, sign flips 0; without severely affected donors +0.15 (p 0.555, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for FAS in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts